Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML). Issue 13 (10th November 2022)

• Record Type: Journal Article
• Authors: Ball, Brian J.; Arslan, Shukaib; Koller, Paul; Ngo, Dat; Afkhami, Michelle; Salhotra, Amandeep; Al-Malki, Monzr; Aribi, Ahmed; Ali, Haris; Sandhu, Karamjeet; Otoukesh, Salman; Amanam, Idoroenyi; Pourhassan, Hoda; Artz, Andrew; Curtin, Peter; Stein, Anthony; Nakamura, Ryotaro; Marcucci, Guido; Smith, Eileen; Pullarkat, Vinod; Aldoss, Ibrahim
• Is Part Of: Leukemia & lymphoma. Volume 63:Issue 13(2022)
• Page Start: 3232
• Page End: 3236
• Publication Date: 2022-11-10
• Subjects: Leukemia -- Periodicals; Lymphomas -- Periodicals; 616.99419
• DOI: 10.1080/10428194.2022.2116934
• Languages: English
• ISSNs: 1042-8194